LGT Fund Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Buy |
7,642
+596
| +8% | +$242K | 0.27% | 90 |
|
|
2025
Q1 | $3.51M | Sell |
7,046
-2,988
| -30% | -$1.49M | 0.32% | 67 |
|
|
2024
Q4 | $5.22M | Buy |
10,034
+702
| +8% | +$365K | 0.46% | 55 |
|
|
2024
Q3 | $5.72M | Sell |
9,332
-380
| -4% | -$233K | 0.59% | 52 |
|
|
2024
Q2 | $5.37M | Buy |
9,712
+3,457
| +55% | +$1.91M | 0.67% | 44 |
|
|
2024
Q1 | $3.64M | Sell |
6,255
-455
| -7% | -$264K | 1.52% | 19 |
|
|
2023
Q4 | $3.58M | Hold |
6,710
| – | – | 1.53% | 16 |
|
|
2023
Q3 | $3.33M | Sell |
6,710
-345
| -5% | -$171K | 1.62% | 14 |
|
|
2023
Q2 | $3.68M | Sell |
7,055
-895
| -11% | -$467K | 1.69% | 14 |
|
|
2023
Q1 | $4.58M | Sell |
7,950
-2,350
| -23% | -$1.35M | 1.95% | 9 |
|
|
2022
Q4 | $5.67M | Hold |
10,300
| – | – | 2.45% | 8 |
|
|
2022
Q3 | $5.22M | Sell |
10,300
-3,446
| -25% | -$1.75M | 2.45% | 8 |
|
|
2022
Q2 | $7.47M | Buy |
13,746
+5,746
| +72% | +$3.12M | 1.1% | 20 |
|
|
2022
Q1 | $4.74M | Hold |
8,000
| – | – | 0.63% | 36 |
|
|
2021
Q4 | $5.34M | Buy |
+8,000
| New | +$5.34M | 1.54% | 20 |
|